schizophrenia

An atypical antipsychotic approved to treat schizophrenia improved depressive episodes for patients with bipolar disorder, according to an industry-supported trial. In a group of 333 patients with …

Sep 16 2020

Uncategorized

Schizophrenia: Nurture cannot overcome nature

by Clinical Editor

No Comments

In the great nature vs. nurture debate, nature just got a win. UCI research led by Amal Alachkar found that too much of a certain amino acid in utero caused...

Sep 16 2020

Uncategorized

Pamela Turner shooting: Texas police officer indicted in death of woman with schizophrenia last year

by Clinical Editor

No Comments

A police officer has been indicted on charges of aggravated assault more than a year after fatally shooting a schizophrenic woman in Baytown, Texas, a Houston suburb. Baytown officer Juan...

Sep 16 2020

Uncategorized

NIH to promote early intervention for schizophrenia via public-private partnership

by Clinical Editor

No Comments

The National Institutes of Health announced a new public-private partnership, the goal of which is to meet the urgent need for early therapeutic interventions for people at risk of developing...

Sep 16 2020

Uncategorized

NIH public-private partnership to advance early interventions for schizophrenia

by Clinical Editor

No Comments

Effort is part of the Accelerating Medicines Partnership to promote development of effective, targeted treatments.

Sep 15 2020

Uncategorized

Boehringer’s schizophrenia med boosts cognition in phase 2 – FierceBiotech

by Clinical Editor

No Comments

Boehringer’s schizophrenia med boosts cognition in phase 2 FierceBiotech

Sep 15 2020

Uncategorized

Pamela Turner shooting: Texas police officer indicted in death of woman with schizophrenia last year

by Clinical Editor

No Comments

A police officer has been indicted on charges of aggravated assault more than a year after fatally shooting a schizophrenic woman in Baytown, Texas, a Houston suburb. Baytown officer Juan...

Sep 15 2020

Uncategorized

Boehringer’s schizophrenia med boosts cognition in phase 2

by Clinical Editor

No Comments

Boehringer Ingelheim’s schizophrenia hopeful hit the mark in a phase 2 study, helping patients overcome cognitive impairment that can affect everyday tasks, such as remembering important dates or …